NCT03438162View on ClinicalTrials.gov

Impact of Pharmacotherapeutic Education on Medication Adherence and Adverse Outcomes in Type 2 Diabetes

NACompletedINTERVENTIONAL

Enrollment

130

Participants

Timeline

Start Date

April 1, 2018

Primary Completion Date

July 1, 2018

Study Completion Date

July 1, 2018

Conditions

Diabetes Mellitus, Type 2EducationDrug-Related Side Effects and Adverse Reactions

Interventions

BEHAVIORAL

Education

Patients randomized in the intervention group received pre-discharge pharmacotherapeutic education. The education was conducted by a qualified physician.

Trial Locations (1)

10000

University Hospital Dubrava, Zagreb

All Listed Sponsors

lead

University Hospital Dubrava

OTHER

NCT03438162 - Impact of Pharmacotherapeutic Education on Medication Adherence and Adverse Outcomes in Type 2 Diabetes | Biotech Hunter | Biotech Hunter